Chromium picolinate inhibits resistin secretion in insulin-resistant 3t3-l1 adipocytes via activation of amp-activated protein kinase

Clinical and Experimental Pharmacology and Physiology

Volumn 36, Issue 8, 2009, Pages 843-849

  Wang, Yi Qun ^a   Dong, Yi ^a   Yao, Ming Hui ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

3T3 L1 adipocytes; AMP activated protein kinase; Chromium picolinate; Insulin resistance; Resistin

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ADIPONECTIN; CHROMIUM PICOLINATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MESSENGER RNA; RESISTIN;

ADIPOCYTE; ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; GENETIC TRANSCRIPTION; IMMUNOBLOTTING; IN VITRO STUDY; INHIBITION KINETICS; INSULIN RESISTANCE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

3T3-L1 CELLS; ADIPOCYTES; ADIPONECTIN; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; DIABETES MELLITUS, TYPE 2; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HYPOGLYCEMIC AGENTS; IMMUNOBLOTTING; INSULIN RESISTANCE; MICE; PICOLINIC ACIDS; RESISTIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC;

EID: 67649230438     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2009.05164.x     Document Type: Article

References (40)

1. Sahin K, Onderci M, Tuzcu M et al. Effect of chromium on carbohydrate and lipid metabolism in a rat model of type 2 diabetes mellitus: The fat-fed, streptozotocin-treated rat. Metabolism 2007 56 : 1233 40.
2. Vladeva SV, Terzieva DD, Arabadjiiska DT. Effect of chromium on the insulin resistance in patients with type II diabetes mellitus. Folia Med. 2005 47 : 59 62.
3. Anderson RA. Chromium in the prevention and control of diabetes. Diabetes Metab. 2000 26 : 22 7.
4. Wang H, Kruszewski A, Brautiqun DL. Cellular chromium enhances activation of insulin receptor kinase. Biochemistry 2005 44 : 8167 75.
5. Wang ZQ, Zhang XH, Russell JC, Hulver M, Cefalu WT. Chromium picolinate enhances skeletal muscle cellular insulin signaling in vivo in obese, insulin-resistant JCR:LA-cp rats. J. Nutr. 2006 136 : 415 20.
6. Chen G, Liu P, Pattar GR et al. Chromium activates glucose transporter 4 trafficking and enhances insulin-stimulated glucose transport in 3T3-L1 adipocytes via a cholesterol-dependent mechanism. Mol. Endocrinol. 2006 20 : 857 70.
7. Nawrocki AR, Scherer PE. Keynote review: The adipocyte as a drug discovery target. Drug Discov. Today 2005 10 : 1219 30.
8. Tilg H, Moschen AR. Adipocytokines: Mediators linking adipose tissue, inflammation and immunity. Nat. Rev. Immunol. 2006 6 : 772 83.
9. Arner P. Insulin resistance in type 2 diabetes: Role of the adipokines. Curr. Mol. Med. 2005 5 : 333 9.
10. Fruebis J, Tsao TS, Javorschi S et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc. Natl Acad. Sci. USA 2001 98 : 2005 10.
11. Weyer C, Funahashi T, Tanaka S et al. Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab. 2001 86 : 1930 5.
12. Shklyaev S, Aslanidi G, Tennant M et al. Sustained peripheral expression of transgene adiponectin offsets the development of diet-induced obesity in rats. Proc. Natl Acad. Sci. USA 2003 100 : 14 217 22.
13. McTernan PG, Kusminski CM, Kumar S. Resistin. Curr. Opin. Lipidol. 2006 17 : 170 5.
14. Muse ED, Obici S, Bhanot S et al. Role of resistin in diet-induced hepatic insulin resistance. J. Clin. Invest. 2004 114 : 232 9.
15. Steppan CM, Bailey ST, Bhat S et al. The hormone resistin links obesity to diabetes. Nature 2001 409 : 307 12.
16. Moon B, Kwan JJ, Duddy N, Sweeney G, Begum N. Resistin inhibits glucose uptake in L6 cells independently of changes in insulin signaling and GLUT4 translocation. Am. J. Physiol. Endocrinol. Metab. 2003 285 : E106 15.
17. Degawa-Yamauchi M, Bovenkerk JE, Juliar BE et al. Serum resistin (FIZZ3) protein is increased in obese humans. J. Clin. Endocrinol. Metab. 2003 88 : 5452 5.
18. Youn BS, Yu KY, Park HJ et al. Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 2004 89 : 150 6.
19. Yamauchi T, Kamon J, Minokoshi Y et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 2002 8 : 1288 95.
20. Banerjee RR, Rangwala SM, Shapiro JS et al. Regulation of fasted blood glucose by resistin. Science 2004 303 : 1195 8.
21. Lihn AS, Jessen N, Pedersen SB, Lund S, Richelsen B. AICAR stimulates adiponectin and inhibits cytokines in adipose tissue. Biochem. Biophys. Res. Commun. 2004 316 : 853 8.
22. Ross SA, Chen X, Hope HR, Sun S, McMahon EG, Broschat K, Gulve EA. Development and comparison of two 3T3-L1 adipocyte models of insulin resistance: Increased glucose flux vs glucosamine treatment. Biochem. Biophys. Res. Commun. 2000 273 : 1033 41.
23. Lowry OH, Rosebrough NJ, Farr AL, Randndall RJ. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951 193 : 265 75.
24. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 2004 89 : 2548 56.
25. Vettor R, Milan G, Rossato M, Federspil G. Review article: Adipocytokines and insulin resistance. Aliment. Pharmacol. Ther. 2005 22 (Suppl. 2 3 10.
26. Ahima RS, Osei SY. Adipokines in obesity. Front. Horm. Res. 2008 36 : 182 97.
27. Goldstein BJ, Scalia R. Adiponectin: A novel adipokine linking adipocytes and vascular function. J. Clin. Endocrinol. Metab. 2004 89 : 2563 8.
28. Kim KH, Lee K, Moon YS, Sul HS. A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J. Biol. Chem. 2001 276 : 11 252 6.
29. Wolf G. Insulin resistance and obesity: Resistin, a hormone secreted by adipose tissue. Nutr. Rev. 2004 62 : 389 94.
30. Hotta K, Funahashi T, Arita Y et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 2000 20 : 1595 9.
31. Proctor SD, Kelly SE, Stanhope KL, Havel PJ, Russell JC. Synergistic effects of conjugated linoleic acid and chromium picolinate improve vascular function and renal pathophysiology in the insulin-resistant JCR:LA-cp rat. Diabetes Obes. Metab. 2007 9 : 87 95.
32. Chen YH, Hung PF, Kao YH. IGF-I downregulates resistin gene expression and protein secretion. Am. J. Physiol. Endocrinol. Metab. 2005 288 : E1019 27.
33. Felipe F, Bonet ML, Ribot J, Palou A. Modulation of resistin expression by retinoic acid and vitamin A status. Diabetes 2004 53 : 882 9.
34. Shojima N, Sakoda H, Ogihara T et al. Humoral regulation of resistin expression in 3T3-L1 and mouse adipose cells. Diabetes 2002 51 : 1737 44.
35. Kahn BB, Alquier T, Carling D, Hardie DG. AMP-activated protein kinase. Ancient energy gauge provides clues to modern understanding of metabolism. Cell. Metab. 2005 1 : 15 25.
36. Liu G, Grifman M, Macdonald J, Moller P, Wong-Staal F, Li QX. Isoginkgetin enhances adiponectin secretion from differentiated adiposarcoma cells via a novel pathway involving AMP-activated protein kinase. J. Endocrinol. 2007 194 : 569 78.
37. Huypens P, Quartier E, Pipeleers D, Van de Casteele M. Metformin reduces adiponectin protein expression and release in 3T3-L1 adipocytes involving activation of AMP activated protein kinase. Eur. J. Pharmacol. 2005 518 : 90 5.
38. Hardie DG. The AMP-activated protein kinase pathway: New players upstream and downstream. J. Cell. Sci. 2004 117 : 5479 87.
39. Carling D. AMP-activated protein kinase: Balancing the scales. Biochimie 2005 87 : 87 91. (Pubitemid 40298770)
40. Saha AK, Ruderman NB. Malonyl-CoA and AMP-activated protein kinase: An expanding partnership. Mol. Cell. Biochem. 2003 253 : 65 70.